Last reviewed · How we verify
Citrobacter Pneumonia
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Gentamicin · Merck & Co.
- Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Ceftazidim · Tel-Aviv Sourasky Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Citrobacter Pneumonia patent landscape — cliff calendar, originator estates, attackable patents
- Citrobacter Pneumonia treatment landscape brief
- Citrobacter Pneumonia treatment updates RSS
Frequently asked questions about Citrobacter Pneumonia
What drugs treat Citrobacter Pneumonia?
Tracked treatments include Ramycin, Garamycin, Gentamicin, Fortaz, Ceftazidim.
What is the treatment for Citrobacter Pneumonia?
Standard treatment for Citrobacter Pneumonia includes Ramycin, Garamycin, Gentamicin, Fortaz, Ceftazidim. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Citrobacter Pneumonia patent cliff · Citrobacter Pneumonia CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Gentamicin · Merck & Co.
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Fortaz · Pai Holdings Pharm
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing